EU approves MAVIRET for acute hepatitis C treatment

EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer

Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b

FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma

Lupin announces US launch of Azilsartan Medoxomil Tablets

Akeso reports Phase II data for ligufalimab in AML

Innoviva Specialty Therapeutics signs licensing agreement with Dr. Reddy's for XACDURO international expansion

Halia Therapeutics' ofirnoflast granted FDA Fast Track designation for lower-risk myelodysplastic syndromes

Inhibrx's ozekibart BLA accepted by FDA for chondrosarcoma treatment

Bayer receives FDA approval for AMBELVIST MRI contrast agent

AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer

Transcend Therapeutics acquired by Otsuka Pharmaceutical

Rocket Pharmaceuticals closes USD180m Rare Pediatric Disease voucher sale

Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study